ZNF815P

Across TCGA pan-cancer cohorts, ZNF815P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZNF815P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ZNF815P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF815P expression acts as an unfavorable survival marker.

SKCM and MESO are the cancer types where ZNF815P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.100	0.737	<.001	12	view →
MESO	DFS	Median	III,IV	0.078	0.376	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ZNF815P–SKCM (DFS)

Open the SKCM breakdown →